DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Bakker J, Grover R, McLuckie A. et al; Glaxo Wellcome International Septic Shock Study Group.
Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Crit Care Med 2004;
32 (01) 1-12
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.